YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

News Blast

June 14, 2005

Genizon BioSciences of Montreal acquired Sweden-based Global Genomics AB. The acquisition of a novel sequencing technology and proprietary algorithms for data analysis will “reduce from months to weeks the time required to identify disease-causing mutations at gene locations identified in our whole genome association studies,” CEO John Hooper says.

Toronto-based Tm Bioscience has received FDA clearance for the Tag-It Cystic Fibrosis Kit, making it the first multiplexed human disease genotyping test to be cleared by the FDA as an in vitro device for diagnostic use in the United States. Such clearance “provides a highly standardized product for laboratories that offers tremendous benefits to physicians and patients,” says Dr. Michael Watson, executive director, American College of Medical Genetics.

Applied Biosystems, in collaboration with Dartmouth Medical School, announces results from a study suggesting the possible involvement of micro-RNAs (miRNAs) in the development of certain cancers. Their study shows that miRNA assays enable sensitive detection and quantification of regulatory molecules in brain cancer.

View Next Related Story
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.